摘要
Introduction Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide,with an increasing incidence in the United States and Europe,and the third most common cause of cancer-related death worldwide[1-2].Based on the GLOBOCAN 2008 estimates,about 748 300 new liver cancer cases and 695 900 cancer deaths occurred worldwide in 2008,collected and made available by the World Health Organization (WHO)[3].Surgical resection,local ablation and liver transplantation are the mainstay of tre...
出处
《中华临床医师杂志(电子版)》
CAS
2011年第11期3229-3233,共5页
Chinese Journal of Clinicians(Electronic Edition)